Ellen Weisberg, Martin Sattler. A novel combination therapy approach for the treatment of acute myeloid leukemia: the multi-kinase inhibitor sorafenib and the HDM2 inhibitor nutlin-3. haematol [Internet]. 2012Nov.2 [cited 2024Nov.27];97(11):1620-1. Available from: https://haematologica.org/article/view/6458